Denali Therapeutics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DNLI Nasdaq 2836 https://www.denalitherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Denali Therapeutics Inc

The Consensus EPS Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Just Fell Dramatically - Mar 4th, 2023 12:35 pm
Denali (DNLI) Q4 Earnings Beat Estimates, Pipeline in Focus - Feb 28th, 2023 2:01 pm
Denali Therapeutics Inc. (DNLI) Reports Q4 Loss, Tops Revenue Estimates - Feb 27th, 2023 10:35 pm
Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights - Feb 27th, 2023 9:01 pm
Denali Therapeutics Reveals New Interim Data From Early-Stage Hunter Syndrome Study - Feb 23rd, 2023 4:15 pm
Denali Therapeutics Announces New Interim Data from DNL310 Phase 1/2 Study for MPS II and DNL126 Preclinical Data for MPS IIIA at WORLDSymposium™ - Feb 22nd, 2023 9:33 pm
Heska (HSKA) Earnings Expected to Grow: Should You Buy? - Feb 21st, 2023 3:00 pm
Earnings Preview: Denali Therapeutics Inc. (DNLI) Q4 Earnings Expected to Decline - Feb 20th, 2023 3:00 pm
Denali Therapeutics Announces Presentations on Enzyme Transport Vehicle (ETV) Development Programs for MPS Diseases at the Upcoming WORLDSymposium™ - Feb 15th, 2023 9:01 pm
Denali Therapeutics Inc. (DNLI) Surges 5.8%: Is This an Indication of Further Gains? - Feb 3rd, 2023 6:22 pm
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in Multiple Sclerosis by Sanofi - Jan 25th, 2023 1:00 pm
Denali Therapeutics Announces Key Anticipated 2023 Milestones for Its Therapeutic Portfolio for Neurodegeneration and Lysosomal Storage Diseases - Jan 9th, 2023 1:00 pm
With 63% ownership, Denali Therapeutics Inc. (NASDAQ:DNLI) boasts of strong institutional backing - Jan 2nd, 2023 11:56 am
Let's Take a Technical Peek at Denali Therapeutics - Dec 13th, 2022 1:15 pm
We're Not Very Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate - Dec 6th, 2022 11:35 am
Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial - Dec 5th, 2022 12:00 pm
Denali Therapeutics Third Quarter 2022 Earnings: Misses Expectations - Nov 9th, 2022 10:32 am
Denali (DNLI) Lags Q3 Earnings Estimates, Pipeline in Focus - Nov 4th, 2022 3:52 pm
Analysts' Revenue Estimates For Denali Therapeutics Inc. (NASDAQ:DNLI) Are Surging Higher - Nov 4th, 2022 10:23 am
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates - Nov 3rd, 2022 9:55 pm